These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32613686)

  • 41. Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications.
    Jonasson C; Hatlebakk JG; Lundell L; Kouri JP; Andersen M; Granath F
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):531-8. PubMed ID: 23269097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study.
    Tran-Duy A; Connell NJ; Vanmolkot FH; Souverein PC; de Wit NJ; Stehouwer CDA; Hoes AW; de Vries F; de Boer A
    J Intern Med; 2019 Feb; 285(2):205-214. PubMed ID: 30141278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study.
    Lei WY; Wang JH; Yi CH; Liu TT; Hung JS; Wong MW; Bair MJ; Vaezi MF; Orr WC; Chen CL
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101397. PubMed ID: 32224118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cigarette smoking and risk of rosacea: a nationwide population-based cohort study.
    Dai YX; Yeh FY; Chou YJ; Chang YT; Chen TJ; Li CP; Wu CY
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2593-2599. PubMed ID: 32401404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom.
    Spoendlin J; Voegel JJ; Jick SS; Meier CR
    J Am Acad Dermatol; 2013 Sep; 69(3):399-406. PubMed ID: 23643255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication.
    Nguyen LH; Lochhead P; Joshi AD; Cao Y; Ma W; Khalili H; Rimm EB; Rexrode KM; Chan AT
    Gastroenterology; 2018 Apr; 154(5):1290-1297.e1. PubMed ID: 29269313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between proton pump inhibitors and risk of pyogenic liver abscess.
    Lin HF; Liao KF; Chang CM; Lin CL; Lai SW
    Eur J Clin Pharmacol; 2017 Aug; 73(8):1019-1025. PubMed ID: 28434021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C.
    Kao WY; Su CW; Chia-Hui Tan E; Lee PC; Chen PH; Tang JH; Huang YH; Huo TI; Chang CC; Hou MC; Lin HC; Wu JC
    Hepatology; 2019 Mar; 69(3):1151-1164. PubMed ID: 30175498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case-Control Study.
    Peng YC; Lin CL; Hsu WY; Lu IT; Yeh HZ; Chang CS; Kao CH
    Dose Response; 2018; 16(4):1559325818803283. PubMed ID: 30288155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations between proton pump inhibitors and Alzheimer's disease: a nested case-control study using a Korean nationwide health screening cohort.
    Choi HG; Kim JH; Kim JH; Kim ES; Park HY; Min KW; Kwon MJ
    Alzheimers Res Ther; 2022 Jul; 14(1):91. PubMed ID: 35773740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
    Hwang IC; Chang J; Park SM
    PLoS One; 2017; 12(12):e0189114. PubMed ID: 29216279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study.
    Wang YT; Tsai MC; Wang YH; Wei JC
    Front Pharmacol; 2020; 11():607. PubMed ID: 32457614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
    Wu CL; Lei WY; Wang JS; Lin CE; Chen CL; Wen SH
    PLoS One; 2020; 15(11):e0242975. PubMed ID: 33253311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based study.
    Labenz C; Wörns MA; Adarkwah CC; Galle PR; Schattenberg JM; Kostev K
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1042-1050. PubMed ID: 32729625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.
    Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton-pump inhibitor use and hip fractures in men: a population-based case-control study.
    Adams AL; Black MH; Zhang JL; Shi JM; Jacobsen SJ
    Ann Epidemiol; 2014 Apr; 24(4):286-90. PubMed ID: 24507954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.
    Chen CH; Lin CL; Kao CH
    Osteoporos Int; 2016 Jun; 27(6):2117-26. PubMed ID: 26860609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.